{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:29:14Z","timestamp":1787668154404,"version":"build-2736575974"},"reference-count":49,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Immunogenetic association studies may give rise to new hypotheses on the immune surveillance of cancer. We hypothesized that certain combinations of killer immunoglobulin-like receptor (KIR) and HLA genotypes may enhance natural killer (NK) cell immunity against nascent acute myeloid leukemia (AML) and, thereby, lead to a skewed genotype distribution among patients. For this purpose, we analyzed KIR and HLA genotypes of 1767 German patients with AML and compared the results with that of the data of 51\u2009890 German volunteers who had registered with German bone marrow donor file (DKMS). Patient samples were retrieved from the Collaborative Biobank and the biorepository of the Study Alliance Leukemia. All samples were genotyped with high-resolution amplicon-based next-generation sequencing. Because of the large number of controls, this study was very sensitive to detect the impact of KIR genotype. Knowledge on KIRs and their cognate HLA ligands allowed for testing of several hypotheses of NK cell\u2013mediated endogenous leukemia surveillance. We did not find significant differences between the 2 cohorts in regard to the presence or absence of single KIR genes. When grouped based on telomeric or centromeric gene content, the major haplotypes A\/A, A\/B, and B\/B were equally distributed among patients and control subjects. Using information on KIRs and their HLA ligands, we further tested receptor-ligand models and summation models without revealing markedly significant differences between patients and controls, albeit we observed a trend pointing at a minor protective effect of a low number of inhibitory KIR\/KIR-ligand pairs. The results suggest that the KIR\/KIR-ligand genotype has no effect on the susceptibility for the development of de novo AML.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022008514","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T21:14:12Z","timestamp":1674508452000},"page":"2994-3004","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Large case-control study indicates no association of <i>KIR<\/i> genotype and risk of developing acute myeloid leukemia"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8525-2810","authenticated-orcid":false,"given":"Falk","family":"Heidenreich","sequence":"first","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"},{"name":"2Clinical Trials Unit, DKMS gGmbH, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bose","family":"Falk","sequence":"additional","affiliation":[{"name":"2Clinical Trials Unit, DKMS gGmbH, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Baldauf","sequence":"additional","affiliation":[{"name":"2Clinical Trials Unit, DKMS gGmbH, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Massalski","sequence":"additional","affiliation":[{"name":"3DKMS Life Science Lab, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesine","family":"Sch\u00e4fer","sequence":"additional","affiliation":[{"name":"3DKMS Life Science Lab, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-031X","authenticated-orcid":false,"given":"Elke","family":"R\u00fccker-Braun","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"},{"name":"2Clinical Trials Unit, DKMS gGmbH, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Altmann","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-2945","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Sauter","sequence":"additional","affiliation":[{"name":"4DKMS gGmbH, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-7510","authenticated-orcid":false,"given":"Ute V.","family":"Solloch","sequence":"additional","affiliation":[{"name":"4DKMS gGmbH, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6442-9573","authenticated-orcid":false,"given":"Vinzenz","family":"Lange","sequence":"additional","affiliation":[{"name":"3DKMS Life Science Lab, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0653-5332","authenticated-orcid":false,"given":"Friedrich","family":"St\u00f6lzel","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"R\u00f6llig","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Middeke","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"von Bonin","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1241-2048","authenticated-orcid":false,"given":"Christian","family":"Thiede","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Sch\u00e4fer-Eckart","sequence":"additional","affiliation":[{"name":"5Klinik f\u00fcr Innere Medizin V, Klinikum N\u00fcrnberg Nord, N\u00fcrnberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7166-5232","authenticated-orcid":false,"given":"Carsten","family":"M\u00fcller-Tidow","sequence":"additional","affiliation":[{"name":"6Medizinische Klinik V, Heidelberg Universit\u00e4tsklinikum, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5259-4651","authenticated-orcid":false,"given":"Stefan W.","family":"Krause","sequence":"additional","affiliation":[{"name":"7Medizinische Klinik V, Erlangen Universit\u00e4tsklinikum, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Kraus","sequence":"additional","affiliation":[{"name":"8Department of Internal Medicine II, University Hospital of W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"9Abteilung f\u00fcr H\u00e4matologie, Onkologie und Palliativmedizin, Robert-Bosch-Krankenhaus, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"H\u00e4nel","sequence":"additional","affiliation":[{"name":"10Medizinische Klinik III, Klinikum Chemnitz, Chemnitz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-5516","authenticated-orcid":false,"given":"Hubert","family":"Serve","sequence":"additional","affiliation":[{"name":"11Medizinische Klinik II, Frankfurt Universit\u00e4tsklinikum, Frankfurt am Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7606-8760","authenticated-orcid":false,"given":"Andreas","family":"Neubauer","sequence":"additional","affiliation":[{"name":"12Klinik f\u00fcr H\u00e4matologie, Onkologie, Immunologie, Philipps Universit\u00e4t Marburg, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-3029","authenticated-orcid":false,"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0979-5914","authenticated-orcid":false,"given":"Alexander H.","family":"Schmidt","sequence":"additional","affiliation":[{"name":"2Clinical Trials Unit, DKMS gGmbH, Dresden, Germany"},{"name":"3DKMS Life Science Lab, Dresden, Germany"},{"name":"4DKMS gGmbH, T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[{"name":"1Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany"},{"name":"2Clinical Trials Unit, DKMS gGmbH, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"2023071014575886500_bib1","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.3389\/fimmu.2019.02357","article-title":"Natural killer cells in myeloid malignancies: immune surveillance, NK cell dysfunction, and pharmacological opportunities to bolster the endogenous NK cells","volume":"10","author":"Carlsten","year":"2019","journal-title":"Front Immunol"},{"issue":"10","key":"2023071014575886500_bib2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2017-08-752170","article-title":"Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation","volume":"131","author":"Cooley","year":"2018","journal-title":"Blood"},{"issue":"9","key":"2023071014575886500_bib3","doi-asserted-by":"crossref","first-page":"e0163297","DOI":"10.1371\/journal.pone.0163297","article-title":"HLA-F and MHC-I open conformers bind natural killer cell Ig-like receptor KIR3DS1","volume":"11","author":"Burian","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"2023071014575886500_bib4","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.4049\/jimmunol.1300081","article-title":"HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors","volume":"191","author":"Goodridge","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"2023071014575886500_bib5","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1128\/JVI.03586-14","article-title":"Peptide-dependent recognition of HLA-B\u221757:01 by KIR3DS1","volume":"89","author":"O'Connor","year":"2015","journal-title":"J\u00a0Virol"},{"issue":"3","key":"2023071014575886500_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.12684","article-title":"Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology","volume":"150","author":"B\u00e9ziat","year":"2017","journal-title":"Immunology"},{"key":"2023071014575886500_bib49","unstructured":"IPD-KIR\n          . Statistics. Accessed 1 June 2022. https:\/\/www.ebi.ac.uk\/ipd\/kir\/about\/statistics\/."},{"issue":"6-8","key":"2023071014575886500_bib7","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41435-020-00117-1","article-title":"Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER\/PR\/HER2+ patients","volume":"21","author":"Hematian Larki","year":"2020","journal-title":"Genes Immun"},{"issue":"9","key":"2023071014575886500_bib8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.humimm.2013.06.021","article-title":"Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group","volume":"74","author":"Jobim","year":"2013","journal-title":"Hum Immunol"},{"issue":"2","key":"2023071014575886500_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/cells9020514","article-title":"Analysis of killer immunoglobulin-like receptor genes in colorectal cancer","volume":"9","author":"Diaz-Pe\u00f1a","year":"2020","journal-title":"Cells"},{"issue":"8","key":"2023071014575886500_bib10","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ijsu.2014.06.012","article-title":"HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients","volume":"12","author":"Kim","year":"2014","journal-title":"Int J Surg"},{"issue":"10","key":"2023071014575886500_bib11","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.humimm.2010.06.019","article-title":"Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors","volume":"71","author":"Al Omar","year":"2010","journal-title":"Hum Immunol"},{"key":"2023071014575886500_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fgene.2016.00121","article-title":"The impact of KIR polymorphism on the risk of developing cancer: not as strong as imagined?","volume":"7","author":"Augusto","year":"2016","journal-title":"Front Genet"},{"issue":"1","key":"2023071014575886500_bib13","first-page":"8","article-title":"KIR2DS3 is associated with protection against acute myeloid leukemia","volume":"7","author":"Shahsavar","year":"2010","journal-title":"Iran J Immunol"},{"issue":"6","key":"2023071014575886500_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/iji.12509","article-title":"Association of killer-cell immunoglobulin-like receptor genes with acute myelogenous leukaemia","volume":"47","author":"Alavianmehr","year":"2020","journal-title":"Int J Immunogenet"},{"issue":"12","key":"2023071014575886500_bib15","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/sj.leu.2403525","article-title":"Identification of natural killer cell receptor phenotypes associated with leukemia","volume":"18","author":"Verheyden","year":"2004","journal-title":"Leukemia"},{"issue":"25","key":"2023071014575886500_bib16","first-page":"1","article-title":"KIR repertory in patients with hematopoietic diseases and healthy family members","volume":"16","author":"Sugioka","year":"2016","journal-title":"BMC Hematol"},{"issue":"6","key":"2023071014575886500_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1399-0039.2009.01235.x","article-title":"Killer immunoglobulin-like receptors (KIR2DL2 and\/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia","volume":"73","author":"Middleton","year":"2009","journal-title":"Tissue Antigens"},{"issue":"29","key":"2023071014575886500_bib18","doi-asserted-by":"crossref","first-page":"eaao2892","DOI":"10.1126\/sciimmunol.aao2892","article-title":"Inhibitory killer cell immunoglobulin-like receptors strengthen CD8+ T cell\u2013mediated control of HIV-1, HCV, and HTLV-1","volume":"3","author":"Boelen","year":"2018","journal-title":"Sci Immunol"},{"key":"2023071014575886500_bib19","doi-asserted-by":"crossref","first-page":"e39991","DOI":"10.1371\/journal.pone.0039991","article-title":"Activating KIR and HLA Bw4 ligands are associated to decreased susceptibility to pemphigus foliaceus, an autoimmune blistering skin disease","volume":"7","author":"Augusto","year":"2012","journal-title":"PLoS One"},{"issue":"14","key":"2023071014575886500_bib20","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"issue":"20","key":"2023071014575886500_bib21","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2016.70.7059","article-title":"KIR3DL1\/HLA-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation","volume":"35","author":"Boudreau","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"2023071014575886500_bib22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2-3","key":"2023071014575886500_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humimm.2015.01.020","article-title":"Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia","volume":"76","author":"Ku\u015bnierczyk","year":"2015","journal-title":"Hum Immunol"},{"issue":"9","key":"2023071014575886500_bib24","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00251-012-0623-3","article-title":"Killer-cell immunoglobulin-like receptors (KIR) in severe A (H1N1) 2009 influenza infections","volume":"64","author":"Aranda-Romo","year":"2012","journal-title":"Immunogenetics"},{"key":"2023071014575886500_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-016-0255-4","article-title":"The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma","volume":"9","author":"La Nasa","year":"2016","journal-title":"J\u00a0Hematol Oncol"},{"issue":"2","key":"2023071014575886500_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/0008-5472.CAN-15-0547","article-title":"Skin cancer risk is modified by KIR\/HLA interactions that influence the activation of natural killer immune cells","volume":"76","author":"Vineretsky","year":"2016","journal-title":"Cancer Res"},{"issue":"4","key":"2023071014575886500_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1182\/bloodadvances.2019001053","article-title":"KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation","volume":"4","author":"Weisdorf","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"2023071014575886500_bib28","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1016\/j.celrep.2018.11.014","article-title":"Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis","volume":"25","author":"Osorio","year":"2018","journal-title":"Cell Rep"},{"issue":"6","key":"2023071014575886500_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00262-008-0601-7","article-title":"Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by natural killer cells","volume":"58","author":"Verheyden","year":"2009","journal-title":"Cancer Immunol Immunother"},{"issue":"9","key":"2023071014575886500_bib30","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/leu.2012.68","article-title":"Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy","volume":"26","author":"Dubois","year":"2012","journal-title":"Leukemia"},{"key":"2023071014575886500_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1471-2164-15-63","article-title":"Cost-efficient high-throughput HLA typing by MiSeq amplicon sequencing","volume":"15","author":"Lange","year":"2014","journal-title":"BMC Genomics"},{"key":"2023071014575886500_bib32","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.3389\/fimmu.2018.02843","article-title":"Allele-level KIR genotyping of more than a million samples: workflow, algorithm, and observations","volume":"9","author":"Wagner","year":"2018","journal-title":"Front Immunol"},{"issue":"8","key":"2023071014575886500_bib33","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.1502469","article-title":"KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV","volume":"196","author":"Boudreau","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"2023071014575886500_bib34","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.7049","article-title":"Role of killer cell immunoglobulin-like receptor (KIR)-ligand interactions to prevent relapse in patients (pts) receiving matched unrelated stem cell transplant (SCT) for acute myeloid leukemia (AML)","author":"Rafei","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"2023071014575886500_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.bbmt.2019.10.016","article-title":"Killer immunoglobulin-like receptor-ligand interactions predict clinical outcomes following unrelated donor transplants killer immunoglobulin-like receptor-ligand interactions predict clinical","volume":"26","author":"Krieger","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"2023071014575886500_bib36","author":"Cohen","year":"1988"},{"issue":"2","key":"2023071014575886500_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humimm.2016.11.010","article-title":"The impact of KIR2DS4 gene on clinical outcome after hematopoietic stem cell transplantation","volume":"78","author":"Burek Kamenaric","year":"2017","journal-title":"Hum Immunol"},{"issue":"6","key":"2023071014575886500_bib38","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.humimm.2014.04.002","article-title":"Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer","volume":"75","author":"Giebel","year":"2014","journal-title":"Hum Immunol"},{"key":"2023071014575886500_bib39","doi-asserted-by":"crossref","first-page":"104345","DOI":"10.1016\/j.yexmp.2019.104345","article-title":"KIR2DS4, KIR2DL2, and KIR2DS4del are linked with basaloid tumors, lymph node metastasis, advanced stage and metastatic risk in head and neck squamous cell carcinoma","volume":"112","author":"Barani","year":"2020","journal-title":"Exp Mol Pathol"},{"issue":"9","key":"2023071014575886500_bib40","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.4049\/jimmunol.169.9.5118","article-title":"Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets","volume":"169","author":"Hsu","year":"2002","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"2023071014575886500_bib41","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4049\/jimmunol.1501358","article-title":"Polymorphic HLA-C receptors balance the functional characteristics of KIR haplotypes","volume":"195","author":"Hilton","year":"2015","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"2023071014575886500_bib42","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2009-09-245746","article-title":"Education of human natural killer cells by activating killer cell immunoglobulin-like receptors","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"2023071014575886500_bib50","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/leu.2008.108","article-title":"Association of KIR2DS4 and its variant KIR1D with leukemia","volume":"22","author":"Giebel","year":"2008","journal-title":"Leukemia"},{"key":"2023071014575886500_bib44","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3389\/fimmu.2019.01646","article-title":"Natural killer cells offer differential protection from leukemia in Chinese Southern Han","volume":"10","author":"Deng","year":"2019","journal-title":"Front Immunol"},{"issue":"24","key":"2023071014575886500_bib45","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2016-05-713099","article-title":"KIR gene haplotype: an independent predictor of clinical outcome in MDS patients","volume":"128","author":"Stringaris","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2023071014575886500_bib46","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/eji.200425089","article-title":"Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific","volume":"34","author":"Hansasuta","year":"2004","journal-title":"Eur J Immunol"},{"key":"2023071014575886500_bib47","doi-asserted-by":"crossref","first-page":"106230","DOI":"10.1016\/j.leukres.2019.106230","article-title":"Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation","volume":"87","author":"Nakamura","year":"2019","journal-title":"Leuk Res"},{"issue":"1","key":"2023071014575886500_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12985-022-01884-1","article-title":"Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence","volume":"19","author":"Jankovi\u0107","year":"2022","journal-title":"Virol J"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/13\/2994\/2062780\/blooda_adv-2022-008514-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/13\/2994\/2062780\/blooda_adv-2022-008514-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T15:00:16Z","timestamp":1689001216000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/13\/2994\/494213\/Large-case-control-study-indicates-no-association"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":49,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,7,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022008514","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]}}}